Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alvotech Swiss Ag

Clinical trials sponsored by Alvotech Swiss Ag, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drug AVT29 takes on eylea HD in DME trial Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Completed 1 Terminated 1

New biosimilar AVT16 takes on entyvio for ulcerative colitis

Disease control Stopped early

This phase 3 trial compared AVT16, a proposed biosimilar, to the approved drug Entyvio (vedolizumab) in 301 adults with moderate to severe ulcerative colitis. Participants received IV infusions over nearly a year. The study aimed to see if AVT16 works as well and is as safe as En…

Phase 3 • Sponsor: Alvotech Swiss AG • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC